Seán Senn 沈 覺 源

Seán Senn 沈 覺 源

Director, Life Science Innovation, New Ventures, And Intellectual Property @ CommonSpirit Health

About Seán Senn 沈 覺 源

Seán Senn is a Director of Life Science Innovation, New Ventures, and Intellectual Property at CommonSpirit Health, with extensive experience in law and biotechnology. He holds multiple degrees, including an M.S. in Molecular Biology and a J.D., and has worked in various roles across the life sciences sector, including as a co-founder of Immix Biopharma, Inc.

Work at CommonSpirit Health

Seán Senn serves as the Director of Life Science Innovation, New Ventures, and Intellectual Property at CommonSpirit Health. He has held this position since 2021. In this role, he focuses on integrating innovative life science initiatives and managing intellectual property strategies to enhance healthcare solutions.

Education and Expertise

Seán Senn holds multiple degrees, including a Master of Science in Molecular Biology from Montclair State University, a Master of Business Administration from UCLA Anderson School of Management, and a Juris Doctor from the University of San Diego School of Law. He is also a PhD candidate in Biochemistry at Rutgers University - Newark. His educational background equips him with a strong foundation in both science and law, particularly in the fields of biotechnology and intellectual property.

Background

Seán Senn has a diverse professional background that spans various roles in the life sciences and legal sectors. He began his career as a Laboratory Researcher at UC San Diego Health and has since held positions such as Intellectual Property Attorney at UCIOTA, Patent Attorney at Davis Wright Tremaine, and Partner at Archer Norris. His experience includes working as General Counsel at fluidIQ and as an Angel Investor at Pasadena Angels.

Achievements

Throughout his career, Seán Senn has contributed to various initiatives in life sciences and intellectual property. He co-founded Immix Biopharma, Inc. in 2010 and has served as a Board Observer at Zharko Pharma since 2022. He is currently involved in developing a novel, nonhormonal treatment for hot flashes at Zharko Pharma, demonstrating his commitment to impactful healthcare solutions.

Values and Philosophy

Seán Senn emphasizes values such as authenticity, integrity, and innovative thinking in his professional and personal life. He believes in the promise of science to advance knowledge and alleviate suffering, and he strives to integrate these values into his work, particularly in projects that have the potential for positive societal impact.

People similar to Seán Senn 沈 覺 源